Related Experiment Video
Updated: Sep 27, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting
Paul H Johnson1, Roger P Walker, Steven W Jones
1Department of Cancer Research, Berlex Biosciences, Richmond, California 94804-0099, USA. JohnsonPaulH@att.net
Abstract:
Drug discovery strategies are needed that can rapidly exploit multiple therapeutic targets associated with the complex gene expression changes that characterize a polygenic disease such as cancer. We report a new cell-based high-throughput technology for screening chemical libraries against several potential cancer target genes in parallel. Multiplex gene expression (MGE) analysis provides direct and quantitative measurement of multiple endogenous mRNAs using a multiplexed detection system coupled to reverse transcription-PCR. A multiplex assay for six genes overexpressed in cancer cells was used to screen 9000 chemicals and known drugs in the human prostate cancer cell line PC-3. Active compounds that modulated gene expression levels were identified, and IC50 values were determined for compounds that bind DNA, cell surface receptors, and components of intracellular signaling pathways. A class of steroids related to the cardiac glycosides was identified that potently inhibited the plasma membrane Na(+)K(+)-ATPase resulting in the inhibition of four of the prostate target genes including transcription factors Hoxb-13, hPSE/PDEF, hepatocyte nuclear factor-3alpha, and the inhibitor of apoptosis, survivin. Representative compounds selectively induced apoptosis in PC-3 cells compared with the nonmetastatic cell line BPH-1. The multiplex assay distinguished potencies among structural variants, enabling structure-activity analysis suitable for chemical optimization studies. A second multiplex assay for five toxicological markers, Hsp70, Gadd153, Gadd45, O6-methylguanine-DNA methyltransferase, and cyclophilin, detected compounds that caused DNA damage and cellular stress and was a more sensitive and specific indicator of potential toxicity than measurement of cell viability. MGE analysis facilitates rapid drug screening and compound optimization, the simultaneous measurement of toxicological end points, and gene function analysis.
Insights
A new multiplex gene expression (MGE) assay rapidly screens thousands of chemicals for cancer drug discovery. This technology identifies potent steroids that inhibit cancer genes and assesses compound toxicity, accelerating therapeutic development.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Cancer is a complex polygenic disease requiring novel drug discovery strategies targeting multiple genes.
- Existing methods struggle to efficiently screen for compounds affecting multiple cancer-related targets simultaneously.
Purpose of the Study:
- To develop and validate a cell-based, high-throughput screening technology for identifying drug candidates against multiple cancer targets.
- To assess the utility of this technology for compound optimization and toxicological profiling.
Main Methods:
- Developed a Multiplex Gene Expression (MGE) analysis using multiplexed detection coupled to reverse transcription-PCR for quantitative mRNA measurement.
- Screened 9000 chemicals against six overexpressed cancer genes in PC-3 prostate cancer cells.
- Utilized a second MGE assay to measure five toxicological markers (Hsp70, Gadd153, Gadd45, O6-methylguanine-DNA methyltransferase, cyclophilin).
Main Results:
- Identified a class of steroids (cardiac glycoside analogs) that inhibit Na(+)K(+)-ATPase, downregulating four prostate cancer target genes including transcription factors and survivin.
- Determined IC50 values and performed structure-activity analysis on identified compounds.
- Demonstrated selective induction of apoptosis in cancer cells by representative compounds.
- The toxicological MGE assay detected DNA damage and cellular stress more sensitively than cell viability assays.
Conclusions:
- MGE analysis is a powerful tool for rapid drug screening, compound optimization, and simultaneous assessment of toxicological endpoints in cancer research.
- The identified steroids represent a promising class of compounds for prostate cancer therapy.
- This technology facilitates a deeper understanding of gene function in disease contexts.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
DNA Microarrays
Pharmacogenomics: Identification of New Drug Targets

